Researchers discovered lariocidin, a lasso peptide antibiotic that kills multidrug-resistant bacteria by binding a novel ...

Amid a surge in drug-resistant bacteria, researchers believe they have discovered a new class of antibiotics for the first ...

A natural antibacterial molecule shows clinical promise. Its unusual binding site is on an excellent target: ...

In addition, the Group's subsidiary Viva Biotech Shanghai was successfully restructured into a joint stock limited company on September 27, 2024, as the Group currently holds approximately 72.9% of ...

In the second half of 2024, Langhua Pharmaceutical has undergone the on-site inspection by the FDA which covered six major systems, namely, quality system, materials, production, packaging and ...

Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...

The last time a new class of antibiotics reached the market was nearly three decades ago—but that could soon change, thanks ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

Peptides offer a gentle yet powerful solution for ageing skin, hydration, and repair. While they don’t work overnight, ...

The new technology, developed by a team at the Ulsan National Institute of Science and Technology (UNIST), identifies ...

Now, a team led by researchers at McMaster University in Ontario believe they’ve found a molecule that could lead to a whole ...